Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.


Targeted next-generation sequencing panels to identify genetic alterations in cancers are increasingly becoming an integral part of clinical practice. We report here the design, validation, and implementation of a comprehensive 95-gene next-generation sequencing panel targeted for hematologic malignancies that we named rapid heme panel. Rapid heme panel is… (More)
DOI: 10.1016/j.jmoldx.2016.02.003


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics